Terms: = Liver cancer AND EXT1, ttv, 2131, ENSG00000182197, EXT, Q16394
104 results:
1. Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases.
Wesdorp NJ; Zeeuw JM; Postma SCJ; Roor J; van Waesberghe JHTM; van den Bergh JE; Nota IM; Moos S; Kemna R; Vadakkumpadan F; Ambrozic C; van Dieren S; van Amerongen MJ; Chapelle T; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Marquering HA; Stoker J; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
Eur Radiol Exp; 2023 Dec; 7(1):75. PubMed ID: 38038829
[TBL] [Abstract] [Full Text] [Related]
2. Survival outcomes and quality of life after percutaneous cryoablation for liver metastasis: A systematic review and meta-analysis.
Khanmohammadi S; Behnoush AH; Akhlaghpoor S
PLoS One; 2023; 18(8):e0289975. PubMed ID: 37585405
[TBL] [Abstract] [Full Text] [Related]
3. Pentacyclic Triterpenes from Olive Leaves Formulated in Microemulsion: Characterization and Role in De Novo Lipogenesis in HepG2 Cells.
Vasarri M; Degl'Innocenti D; Albonetti L; Bilia AR; Bergonzi MC
Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569488
[No Abstract] [Full Text] [Related]
4. Finding a Novel Chalcone-Cinnamic Acid Chimeric Compound with Antiproliferative Activity against MCF-7 Cell Line Using a Free-Wilson Type Approach.
Ventura-Salazar IAY; Palacios-Can FJ; González-Maya L; Sánchez-Carranza JN; Antunez-Mojica M; Razo-Hernández RS; Alvarez L
Molecules; 2023 Jul; 28(14):. PubMed ID: 37513358
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of total tumor volume reduction ratio in initially unresectable colorectal liver metastases after first-line systemic treatment.
He J; Li W; Zhou J; Sun H; Zhou C; Liu Y; Quan T; Fan W; Pan Z; Lin J; Peng J
Eur J Radiol; 2023 Aug; 165():110950. PubMed ID: 37437437
[TBL] [Abstract] [Full Text] [Related]
6. The Usefulness of Total Tumor Volume as a Prognostic Factor and in Selecting the Optimal Treatment Strategy of Chemotherapeutic Intervention in Patients with Colorectal liver Metastases.
Shimura Y; Komatsu S; Nagatani Y; Funakoshi Y; Sofue K; Kido M; Kuramitsu K; Gon H; Fukushima K; Urade T; So S; Yanagimoto H; Toyama H; Minami H; Fukumoto T
Ann Surg Oncol; 2023 Oct; 30(11):6603-6610. PubMed ID: 37386304
[TBL] [Abstract] [Full Text] [Related]
7. Targeting transglutaminase 2 mediated exostosin glycosyltransferase 1 signaling in liver cancer stem cells with acyclic retinoid.
Qin XY; Furutani Y; Yonezawa K; Shimizu N; Kato-Murayama M; Shirouzu M; Xu Y; Yamano Y; Wada A; Gailhouste L; Shrestha R; Takahashi M; Keillor JW; Su T; Yu W; Fujii S; Kagechika H; Dohmae N; Shirakami Y; Shimizu M; Masaki T; Matsuura T; Suzuki H; Kojima S
Cell Death Dis; 2023 Jun; 14(6):358. PubMed ID: 37308486
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of quantitative volumetric analysis and linear measurement for predicting the survival of Barcelona Clinic liver cancer 0- and A stage hepatocellular carcinoma after radiofrequency ablation.
Yang S; Zhang Z; Su T; Chen Q; Wang H; Jin L
Diagn Interv Radiol; 2023 May; 29(3):450-459. PubMed ID: 37154818
[TBL] [Abstract] [Full Text] [Related]
9. Comparison of survival rates as predicted by total tumor volume or tumor burden score in patients with hepatocellular carcinoma concurrent with fatty liver disease and hepatitis B virus.
Li MJ; Xie S; Teng YX; Ma L; Li LQ; Xiang BD; Zhong JH
Expert Rev Gastroenterol Hepatol; 2023 May; 17(5):499-507. PubMed ID: 36975382
[TBL] [Abstract] [Full Text] [Related]
10. HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC).
Wang W; Chen Y; Wu L; Zhang Y; Yoo S; Chen Q; Liu S; Hou Y; Chen XP; Chen Q; Zhu J
BMC Med Genomics; 2022 Jun; 15(1):134. PubMed ID: 35710421
[TBL] [Abstract] [Full Text] [Related]
11. Yttrium-90 radioembolization for unresectable hepatocellular carcinoma: predictive modeling strategies to anticipate tumor response and improve patient selection.
Lüdemann W; Kahn J; Pustelnik D; Hardt J; Böning G; Jonczyk M; Amthauer H; Gebauer B; Hamm B; Wieners G
Eur Radiol; 2022 Jul; 32(7):4687-4698. PubMed ID: 35230518
[TBL] [Abstract] [Full Text] [Related]
12. Dual hepatitis B and C-associated hepatocellular carcinoma: clinical characteristics, outcome, and prognostic role of albumin-bilirubin grade.
Ko CC; Ho SY; Liu PH; Hsu CY; Hsia CY; Huang YH; Su CW; Lei HJ; Lee RC; Hou MC; Huo TI
Int J Clin Oncol; 2022 Apr; 27(4):739-748. PubMed ID: 35119581
[TBL] [Abstract] [Full Text] [Related]
13.
van 't Erve I; Wesdorp NJ; Medina JE; Ferreira L; Leal A; Huiskens J; Bolhuis K; van Waesberghe JTM; Swijnenburg RJ; van den Broek D; Velculescu VE; Kazemier G; Punt CJA; Meijer GA; Fijneman RJA
JCO Precis Oncol; 2021; 5():. PubMed ID: 34820593
[TBL] [Abstract] [Full Text] [Related]
14. The ratio of preoperative alpha-fetoprotein level to total tumor volume as a prognostic factor of hepatocellular carcinoma after liver transplantation.
Jiang T; Zhang XS; Pan F; Lyu SC; Wang J; Huang MX; He Q; Lang R
Medicine (Baltimore); 2021 Jul; 100(26):e26487. PubMed ID: 34190174
[TBL] [Abstract] [Full Text] [Related]
15. Identifying enhancement-based staging markers on baseline MRI in patients with colorectal cancer liver metastases undergoing intra-arterial tumor therapy.
Ghani MA; Fereydooni A; Chen E; Letzen B; Laage-Gaupp F; Nezami N; Deng Y; Gan G; Thakur V; Lin M; Papademetris X; Schernthaner RE; Huber S; Chapiro J; Hong K; Georgiades C
Eur Radiol; 2021 Dec; 31(12):8858-8867. PubMed ID: 34061209
[TBL] [Abstract] [Full Text] [Related]
16. Role of 3D quantitative tumor analysis for predicting overall survival after conventional chemoembolization of intrahepatic cholangiocarcinoma.
Rexha I; Laage-Gaupp F; Chapiro J; Miszczuk MA; van Breugel JMM; Lin M; Konstantinidis M; Duran R; Gebauer B; Georgiades C; Hong K; Nezami N
Sci Rep; 2021 Apr; 11(1):9337. PubMed ID: 33927226
[TBL] [Abstract] [Full Text] [Related]
17. Intra- inter-observer repeatability in liver computed tomography volumetry in patients undergoing radioembolization simulation.
Masperi A; Cubadda V; Bombelli L; Labruna R; Bagnardi V; Fodor CI; Pagan E; Bonomo G; Orsi F
Abdom Radiol (NY); 2021 Jul; 46(7):3448-3455. PubMed ID: 33630128
[TBL] [Abstract] [Full Text] [Related]
18. Models to predict disease-free survival for hepatocellular carcinoma patients with surgical resections.
Lai Y; Lee JC; Hung HC; Cheng CH; Wu TH; Lee CF; Wu TJ; Chou HS; Chan KM; Lee WC
J Surg Oncol; 2020 Dec; 122(7):1444-1452. PubMed ID: 32875573
[TBL] [Abstract] [Full Text] [Related]
19. Total tumour volume as a prognostic factor in patients with resectable colorectal cancer liver metastases.
Tai K; Komatsu S; Sofue K; Kido M; Tanaka M; Kuramitsu K; Awazu M; Gon H; Tsugawa D; Yanagimoto H; Toyama H; Murakami S; Murakami T; Fukumoto T
BJS Open; 2020 Jun; 4(3):456-466. PubMed ID: 32277807
[TBL] [Abstract] [Full Text] [Related]
20. Deep convolutional neural network applied to the liver imaging reporting and data system (LI-RADS) version 2014 category classification: a pilot study.
Yamashita R; Mittendorf A; Zhu Z; Fowler KJ; Santillan CS; Sirlin CB; Bashir MR; Do RKG
Abdom Radiol (NY); 2020 Jan; 45(1):24-35. PubMed ID: 31696269
[TBL] [Abstract] [Full Text] [Related]
[Next]
